Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study

Página do item simplificado Estatísticas
dc.contributor.authorSanches, Rafael Faria
dc.contributor.authorOsório, Flávia de Lima
dc.contributor.authorSantos, Rafael G. dos
dc.contributor.authorMacedo, Ligia R.H.
dc.contributor.authorMaia-de-Oliveira, João Paulo
dc.contributor.authorWichert-Ana, Lauro
dc.contributor.authorAraújo, Dráulio Barros de
dc.contributor.authorRiba, Jordi
dc.contributor.authorCrippa, José Alexandre S.
dc.contributor.authorHallak, Jaime E.C.
dc.date.accessioned2017-06-01T19:40:32Z
dc.date.available2017-06-01T19:40:32Z
dc.date.issued2016
dc.description.resumoAyahuasca is an Amazonian botanical hallucinogenic brew which contains dimethyltryptamine, a 5-HT2A receptor agonist, and harmine, a monoamine-oxidase A inhibitor. Our group recently reported that ayahuasca administration was associated with fast-acting antidepressive effects in 6 depressive patients. The objective of the present work was to assess the antidepressive potentials of ayahuasca in a bigger sample and to investigate its effects on regional cerebral blood flow. In an open-label trial conducted in an inpatient psychiatric unit, 17 patients with recurrent depression received an oral dose of ayahuasca (2.2 mL/kg) and were evaluated with the Hamilton Rating Scale for Depression, the Montgomery-Åsberg Depression Rating Scale, the Brief Psychiatric Rating Scale, the Young Mania Rating Scale, and the Clinician Administered Dissociative States Scale during acute ayahuasca effects and 1, 7, 14, and 21 days after drug intake. Blood perfusion was assessed eight hours after drug administration by means of single photon emission tomography. Ayahuasca administration was associated with increased psychoactivity (Clinician Administered Dissociative States Scale) and significant score decreases in depression-related scales (Hamilton Rating Scale for Depression, Montgomery-Åsberg Depression Rating Scale, Brief Psychiatric Rating Scale) from 80 minutes to day 21. Increased blood perfusion in the left nucleus accumbens, right insula and left subgenual area, brain regions implicated in the regulation of mood and emotions, were observed after ayahuasca intake. Ayahuasca was well tolerated. Vomiting was the only adverse effect recorded, being reported by 47% of the volunteers. Our results suggest that ayahuasca may have fast-acting and sustained antidepressive properties. These results should be replicated in randomized, double-blind, placebo-controlled trials.pt_BR
dc.identifier.doi10.1097/JCP.0000000000000436
dc.identifier.urihttps://repositorio.ufrn.br/jspui/handle/123456789/23354
dc.languageengpt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectayahuascapt_BR
dc.subjectdimethyltryptaminept_BR
dc.subjectharminept_BR
dc.subjectmonoamine oxidase inhibitorspt_BR
dc.titleAntidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Studypt_BR
dc.typearticlept_BR

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression.pdf
Tamanho:
276.56 KB
Formato:
Adobe Portable Document Format
Descrição:
DraulioAraujo_ICe_Antidepressant Effects of a Single Dose_2016
Imagem de Miniatura
 Baixar

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Nenhuma Miniatura disponível
Baixar

Coleções

ICe - Artigos publicados em periódicos
Repositório Institucional - UFRN Campus Universitário Lagoa NovaCEP 59078-970 Caixa postal 1524 Natal/RN - BrasilUniversidade Federal do Rio Grande do Norte© Copyright 2025. Todos os direitos reservados.
Contato+55 (84) 3342-2260 - R232Setor de Repositórios Digitaisrepositorio@bczm.ufrn.br
DSpaceIBICT
OasisBR
LAReferencia
Customizado pela CAT - BCZM